Cargando…
Efficacy of immune checkpoint inhibitors in different types of melanoma
Immunotherapy can be used for cutaneous, mucosal, uveal and conjunctival melanoma. Nevertheless, we cannot expect the same benefit from checkpoint inhibitors for all the types of melanoma. The different biological features can explain the variable efficacy. The main results obtained with immune chec...
Autores principales: | Rossi, Ernesto, Schinzari, Giovanni, Maiorano, Brigida Anna, Indellicati, Giulia, Di Stefani, Alessandro, Pagliara, Monica Maria, Fragomeni, Simona Maria, De Luca, Erika Valentina, Sammarco, Maria Grazia, Garganese, Giorgia, Galli, Jacopo, Blasi, Maria Antonietta, Paludetti, Gaetano, Scambia, Giovanni, Peris, Ketty, Tortora, Giampaolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872095/ https://www.ncbi.nlm.nih.gov/pubmed/32663057 http://dx.doi.org/10.1080/21645515.2020.1771986 |
Ejemplares similares
-
Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019) -
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019) -
Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy?
por: Rossi, Ernesto, et al.
Publicado: (2019) -
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients
por: Rossi, Ernesto, et al.
Publicado: (2023) -
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma
por: Rossi, Ernesto, et al.
Publicado: (2023)